VIRTTU BIOLOGICS LTD has a total of 29 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and United Kingdom. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ACCANIS BIOTECH F&E GMBH & CO KG, TERMAN DAVID S and FUNDACAO BUTANTAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | United Kingdom | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | China | 2 | |
#6 | Canada | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Syringes | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Conner Joe | 23 |
#2 | Muthana Munitta | 6 |
#3 | Lewis Claire Elizabeth | 6 |
#4 | Cripe Timothy | 6 |
#5 | Joe Conner | 2 |
Publication | Filing date | Title |
---|---|---|
EP3558377A1 | Treatment of cancer | |
US2017319638A1 | Treatment of cancer | |
GB201706600D0 | Virus preparations | |
GB201703857D0 | Treatment of cancer | |
GB201702565D0 | Treatment of cancer | |
GB201622214D0 | treatment of cancer | |
EP3217993A1 | Treatment of cancer by infusion of oncolytic herpes simplex virus to the blood | |
US2018071348A1 | Oncolytic herpes simplex virus infected cells |